Try the newly designed PSNet website! Learn More
PSNet: Patient Safety Network
Web Resource
Government Resource

Relenza (zanamivir) inhalation powder.

Food and Drug Administration; FDA.

This alert notifies health care providers of the potential for patient harm if a particular inhalation powder is reconstituted and incorrectly administered.